Use your Facebook login and see what your friends are reading and sharing.
SAFC-Global's Documents
EX-CELL® EBx® PRO-II Serum-Free Medium without L-glutamine
EX-CELL® EBx® PRO-II is a chemically defined, animal-component free, serum-free, low-protein liquid medium developed for intracellular virus propagation in EB66® embryonic stem cells in suspension culture.
Category:ScienceReads:1,024Uploaded:04 / 02 / 2010ShareAdd to collectionParticle Size Analysis in Dry Powder Cell Culture Media Production
Product testing is constantly evolving as underlying technologies improve. Particle size determination of comminuted powders – a vital element in dry powder cell culture media production – has existed in various forms for centuries, but modern improvements in the accuracy, range and reporting abilities of particle size analyzers (PSA) have extended our capabilities significantly. With the added accuracy and ease of use that comes with PSA equipment, the trend has been to incorporate these results into product specifications. Do these specifications really add value if there is no scientific backing of the results?
Category:ScienceReads:764Uploaded:03 / 31 / 2010ShareAdd to collectionStoring and Thawing Serum
Animal serum is an excellent source of nutrients for cells in culture because it contains proteins, lipids, salts, vitamins, minerals, amino acids and other components necessary for growth. When stored and handled correctly, the performance characteristics of serum can be maintained for many years. Improperly storing and/or thawing serum products can decrease not only the immediate and long-term stability, but also their effectiveness.
Category:ScienceReads:519Uploaded:03 / 23 / 2010ShareAdd to collectionAn Introduction to High-Potent API Classification
When dealing with highly potent compounds, it’s critical that failsafe procedures are in place relating to their handling, storage and containment. In order to ensure that the correct procedures are installed and adhered to, a logical system of classifying the potency of the High-Potent API (HPAPI) is needed. At present, there is no official guidance regarding the safe handling of highly potent APIs. As a result, the industry has begun self-regulating itself, with standards developed by SafeBridge® Consultants being the most widely recognized classification system.
Category:Brochures/CatalogsReads:6,914Uploaded:11 / 18 / 2009ShareAdd to collectionSAFC Pharma Installs Dual Wavelength X-ray Diffractometer
SAFC PHARMA INSTALLS THE INDUSTRY’S FIRST COMMERCIAL DUAL WAVELENGTH X-RAY DIFFRACTOMETER. Allows Increased Throughput for Challenging Single Crystal Analyses
Category:Magazines/NewspapersReads:543Uploaded:10 / 21 / 2009ShareAdd to collectionSAFC Pharma Complets Contract Manufacturing Facility Expansion
SAFC PHARMA® ANNOUNCES COMPLETION OF $12M CONTRACT MANUFACTURING FACILITY EXPANSION IN CARLSBAD, CALIF. Addition Enhances Capabilities and Capacity Bolsters Biologics and Viral Manufacturing; Reinforces Support for Secure, Successful Customer Launches
Category:Magazines/NewspapersReads:599Uploaded:10 / 21 / 2009ShareAdd to collectionPharmorphix Symposium
St. Louis, MO - August 27, 2009 - SAFC® (www.safcglobal.com), a member of the Sigma- Aldrich® Group (NASDAQ: SIAL), announced today that its SAFC Pharma® business segment will host its first Pharmorphix® Organic Solid State Chemistry Symposium at The Trinity Centre, Cambridge Science Park, UK, from 9:00 a.m. to 4:00 p.m. on September 25, 2009.
Category:TechnologyReads:1,021Uploaded:08 / 28 / 2009ShareAdd to collectionSAFC Pharma-Multi-Purpose Microreactors-A Fast Track to Optimized Processes-2009
Standard batch reactors have long been the workhorse for chemical ingredient and intermediate manufacturing and, although their use is well understood, they do have a number of performance drawbacks and limitations such as poor mixing, limited heat transfer capabilities, and lengthy scale-up phases. These limitations have led to the evaluation of alternative production methods with microreactors, in many instances, offering a more effective solution for chemical manufacture and great potential as a ‘fast track’ to optimized processes.
Category:Brochures/CatalogsReads:927Uploaded:08 / 24 / 2009ShareAdd to collectionPress Release: Sartorius Stedim Biotech Partners with Cell Culture Media Specialist SAFC Biosciences® to Provide World-Class Fluid Management and Liquid/Powder System Solutions
Global agreement strengthens customized manufacturing solutions for upstream and downstream processing and moves the “disposable factory” closer to reality. Sartorius Stedim Biotech and SAFC Biosciences, a business segment of SAFC and member of the Sigma-Aldrich group, both leading suppliers to the biopharmaceutical industry, announced the signing of a global partnership agreement that combines Sartorius Stedim Biotech’s (SSB) expertise in filtration and liquid handling systems with SAFC Biosciences’ proficiency in development and manufacturing of cell culture media and downstream purification products. The alliance is expected to provide more robust and comprehensive solutions to biopharmaceutical manufacturers.
Category:Health & MedicineReads:658Uploaded:07 / 15 / 2009ShareAdd to collectionPress Release: New SAFC Hitech® Product Roadmap Plots Route for Future Generation Semiconductor materials
ST. LOUIS, MO./SEMICON West, San Francisco, CA. – July 15, 2009 – SAFC Hitech®, a business segment within SAFC®, a member of the Sigma-Aldrich® Group, today announced details of its new materials roadmap for Metalorganic Chemical Vapor Deposition (MOCVD) and Atomic Layer Deposition (ALD) processes on silicon semiconductor substrates. The roadmap outlines the development paths across current and future advanced memory and logic devices, which includes barrier layers, interconnects, dielectrics and metals, that the company expects to see play out between now and 2014.
Category:ScienceReads:525Uploaded:07 / 15 / 2009ShareAdd to collection
